| Dr Marc R Baraban, MD | |
|
2902 Sw Asbury Dr, Topeka, KS 66614-4466 | |
| (785) 354-9591 | |
| (785) 327-4142 |
| Full Name | Dr Marc R Baraban |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 49 Years |
| Location | 2902 Sw Asbury Dr, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649231580 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 04-18807 (Kansas) | Secondary |
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 04-18807 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Collaborators in a new nationwide program for hospitals designed to improve the recovery of surgical patients have identified their first set of evidence-based recommendations: a care plan for colon and rectal surgical procedures.
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
Brain tumor tissue can be hard to distinguish from normal brain during surgery. Neurosurgeons use their best judgment in the operating room but often must guess exactly where the edges of the tumor are while removing it.
Up to 7 million people each year receive care in an emergency department (ED) for chest pain, a symptom of a potential heart condition. Over 80 percent of chest pain patients, however, ultimately have no evidence of cardiovascular disease or acute coronary syndrome.
› Verified 2 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Collaborators in a new nationwide program for hospitals designed to improve the recovery of surgical patients have identified their first set of evidence-based recommendations: a care plan for colon and rectal surgical procedures.
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
Brain tumor tissue can be hard to distinguish from normal brain during surgery. Neurosurgeons use their best judgment in the operating room but often must guess exactly where the edges of the tumor are while removing it.
Up to 7 million people each year receive care in an emergency department (ED) for chest pain, a symptom of a potential heart condition. Over 80 percent of chest pain patients, however, ultimately have no evidence of cardiovascular disease or acute coronary syndrome.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marc R Baraban, MD 2902 Sw Asbury Dr, Topeka, KS 66614-4466 Ph: (785) 354-9591 | Dr Marc R Baraban, MD 2902 Sw Asbury Dr, Topeka, KS 66614-4466 Ph: (785) 354-9591 |
News Archive
Collaborators in a new nationwide program for hospitals designed to improve the recovery of surgical patients have identified their first set of evidence-based recommendations: a care plan for colon and rectal surgical procedures.
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
Brain tumor tissue can be hard to distinguish from normal brain during surgery. Neurosurgeons use their best judgment in the operating room but often must guess exactly where the edges of the tumor are while removing it.
Up to 7 million people each year receive care in an emergency department (ED) for chest pain, a symptom of a potential heart condition. Over 80 percent of chest pain patients, however, ultimately have no evidence of cardiovascular disease or acute coronary syndrome.
› Verified 2 days ago
Wade William Stinson Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Topeka, KS 66606 Phone: 785-354-9591 | |
Dr. William E Sachs, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Topeka, KS 66606 Phone: 785-354-9591 | |
Coimbotore Radhakrishna, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-4357 | |
Paul H Kindling, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-0111 | |
Partha Bhurtel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Topeka, KS 66606 Phone: 785-354-9591 | |
James J Hamilton Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 6001 Sw 6th Ave, Suite 220, Topeka, KS 66615 Phone: 785-232-0444 Fax: 785-232-1562 | |
Marjorie M Beebe, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Surgery Service Line 3rd Floor, Topeka, KS 66622 Phone: 785-350-3111 Fax: 785-350-4541 |